Efficacy Study of School-located Influenza Vaccination Clinics to Increase Influenza Vaccination Rates in Monroe County, New York
NCT02227186 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20461
Last updated 2017-05-01
Summary
Children in schools in which influenza vaccination clinics are held during school hours will have higher rates of influenza vaccination than children in control schools (no school-located clinics offered)
Conditions
- Childhood Influenza Vaccination
- School-located Influenza Vaccination
Interventions
- OTHER
-
School-located Influenza Vaccination Clinic
Children in the intervention arm are enrolled in schools in Monroe County, NY that are offering school-located influenza vaccination clinics during school hours
Sponsors & Collaborators
-
University of California, Los Angeles
lead OTHER
Principal Investigators
-
Peter Szilagyi, MPH, MD · University of Rochester
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 4 Years
- Max Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-08-01
- Primary Completion
- 2015-07-31
- Completion
- 2015-07-31
Countries
- United States
Study Locations
More Related Trials
-
Influenza Immunity in Children
NCT02559505 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a School-based Influenza Vaccination Program
NCT00961337 ·Status: COMPLETED ·Phase: PHASE4
-
SAVE: School Ambassadors for Vaccine Education
NCT07164144 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Infectivity, Replication & Immunogenicity of Live nH1N1 Vaccine
NCT01023776 ·Status: COMPLETED ·Phase: PHASE4
-
Development of Childhood Anti-Influenza Immunity
NCT03673345 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Children
NCT01776554 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Age and Prior Immunity on Response to H1N1 Vaccines in Children
NCT01097941 ·Status: WITHDRAWN ·Phase: PHASE4
-
Safety and Immunogenicity Study of a H5N1 Influenza Vaccine (Vero Cell-Derived, Whole Virus) in Healthy Infants, Children and Adolescents
NCT01052402 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Control of Epidemic Influenza Through a School-based Influenza Vaccination Program
NCT00138294 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Trial of an Quadrivalent Inactivated Influenza Vaccine in Healthy Children Aged 6 to 35 Months
NCT05212623 ·Status: COMPLETED ·Phase: PHASE1
-
Administration of the Nasal Influenza Vaccine to Children in Daycare or at a Healthcare Facility
NCT07310472 ·Status: RECRUITING ·Phase: NA
-
Study to Evaluate the Effectiveness of FluMist Vaccination in a School-Based Intervention Program
NCT00192218 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza
NCT01693380 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months
NCT00311428 ·Status: COMPLETED ·Phase: PHASE4
-
The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated) (Children Forms of Drug)
NCT01551823 ·Status: COMPLETED ·Phase: PHASE3
-
Immunologic Response to Inactivated Vaccine for Novel H1N1 Virus
NCT01023711 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Children
NCT00972517 ·Status: COMPLETED ·Phase: PHASE3
-
Collaborative Efforts to Increase Flu Vaccination
NCT01403649 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11
NCT01206114 ·Status: COMPLETED
-
A Study of Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years
NCT00956202 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza Vaccine
NCT02222870 ·Status: COMPLETED ·Phase: PHASE4
-
Immunogenicity, Tolerability and Safety of One or Two Doses of an Adjuvanted Swine-origin A H1N1 Influenza Vaccine in Healthy Subjects 18 or More Years of Age Both Vaccinated and Not Yet Vaccinated Against Seasonal Influenza 2009/10
NCT00992212 ·Status: COMPLETED ·Phase: PHASE2
-
Seasonal Influenza Vaccination Reminders for Children With High-risk Conditions
NCT01431183 ·Status: COMPLETED ·Phase: NA
-
The Effect of Time-Slot Scheduling on Flu Vaccination Rates
NCT01206686 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine (Egg-Derived) in Healthy Subjects From 6 Months to 17 Years of Age
NCT00971542 ·Status: COMPLETED ·Phase: PHASE3